Children's Panadol 1-5 Years Suspension
Published 5 December 2013
Product
GlaxoSmithKline (GSK), in consultation with the TGA, is recalling two batches of Children's Panadol 1-5 years suspension from pharmacies and hospitals as a small proportion of bottles contain higher levels of paracetamol than specified. For more detailed information in relation to the recall, please visit the Therapeutic Goods Administration website. Identifying features description The two affected batches were dispatched from GSK between September and November 2013. The identified batches are: • Children's Panadol 1-5 years suspension (strawberry / 200mL) -(identified by JR130869 on the carton and 130869 on the bottle) • Children's Panadol 1-5 years suspension (orange / 100mL) - (identified by JR130697 on the carton and 130697 on the bottle)
Why it was recalled
The higher levels of paracetamol in the two affected batches may result in doses that are over the recommended and labelled doses but not to the extent that they pose risks to children when the product is used according to the directions on the label.
Hazard
Incorrect dosage may result in illness.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.